Shares of Core Laboratories N.V. (NYSE:CLB) have been given an average recommendation of “Hold” by the seventeen ratings firms that are currently covering the stock, MarketBeat Ratings reports. Four investment analysts have rated the stock with a sell rating, eight have issued a hold rating and five have issued a buy rating on the company. The average 1-year price objective among brokers that have issued a report on the stock in the last year is $113.36.

CLB has been the topic of several analyst reports. Piper Jaffray Companies set a $97.00 price target on Core Laboratories N.V. and gave the company a “hold” rating in a research report on Wednesday, July 26th. Citigroup Inc. decreased their price target on Core Laboratories N.V. from $102.00 to $100.00 and set a “neutral” rating on the stock in a research report on Wednesday, July 26th. ValuEngine upgraded Core Laboratories N.V. from a “sell” rating to a “hold” rating in a research report on Friday, August 4th. Royal Bank Of Canada set a $145.00 price target on Core Laboratories N.V. and gave the company a “buy” rating in a research report on Saturday, June 17th. Finally, Zacks Investment Research cut Core Laboratories N.V. from a “buy” rating to a “hold” rating in a research report on Friday, June 23rd.

ILLEGAL ACTIVITY WARNING: This article was posted by American Banking News and is owned by of American Banking News. If you are viewing this article on another site, it was illegally copied and reposted in violation of US & international trademark & copyright law. The correct version of this article can be viewed at https://www.americanbankingnews.com/2017/09/09/core-laboratories-n-v-clb-given-average-rating-of-hold-by-analysts.html.

Institutional investors and hedge funds have recently modified their holdings of the business. Parallel Advisors LLC boosted its stake in Core Laboratories N.V. by 33.4% in the first quarter. Parallel Advisors LLC now owns 891 shares of the oil and gas company’s stock worth $101,000 after buying an additional 223 shares in the last quarter. Quantbot Technologies LP purchased a new stake in Core Laboratories N.V. in the first quarter worth approximately $106,000. The Manufacturers Life Insurance Company boosted its stake in Core Laboratories N.V. by 63.7% in the second quarter. The Manufacturers Life Insurance Company now owns 1,128 shares of the oil and gas company’s stock worth $114,000 after buying an additional 439 shares in the last quarter. FNY Managed Accounts LLC purchased a new stake in Core Laboratories N.V. in the first quarter worth approximately $123,000. Finally, Shine Investment Advisory Services Inc. purchased a new stake in Core Laboratories N.V. in the second quarter worth approximately $134,000.

Shares of Core Laboratories N.V. (CLB) traded up 0.10% during midday trading on Friday, reaching $91.18. 456,001 shares of the company’s stock were exchanged. Core Laboratories N.V. has a 12 month low of $86.55 and a 12 month high of $125.83. The firm has a 50 day moving average price of $94.24 and a 200 day moving average price of $105.02. The company has a market cap of $4.02 billion, a P/E ratio of 55.94 and a beta of 1.60.

Core Laboratories N.V. (NYSE:CLB) last announced its quarterly earnings results on Monday, July 24th. The oil and gas company reported $0.52 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $0.51 by $0.01. Core Laboratories N.V. had a return on equity of 49.29% and a net margin of 11.80%. The firm had revenue of $163.90 million for the quarter, compared to analysts’ expectations of $168.23 million. During the same period in the prior year, the business posted $0.35 earnings per share. The company’s revenue was up 10.7% on a year-over-year basis. Equities research analysts forecast that Core Laboratories N.V. will post $2.04 earnings per share for the current fiscal year.

The company also recently announced a quarterly dividend, which was paid on Monday, August 14th. Shareholders of record on Monday, July 17th were paid a $0.55 dividend. This represents a $2.20 annualized dividend and a yield of 2.41%. The ex-dividend date was Thursday, July 13th. Core Laboratories N.V.’s dividend payout ratio is currently 134.15%.

About Core Laboratories N.V.

Core Laboratories N.V. provides reservoir description, production enhancement and reservoir management services to the oil and gas industry. The Company operates through three segments: Reservoir Description, Production Enhancement and Reservoir Management. The Reservoir Description segment encompasses the characterization of petroleum reservoir rock, fluid and gas samples.

Analyst Recommendations for Core Laboratories N.V. (NYSE:CLB)

Receive News & Ratings for Core Laboratories N.V. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Core Laboratories N.V. and related companies with MarketBeat.com's FREE daily email newsletter.